Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

Bullboard Posts

Comment by fricky00on Sep 05, 2019 6:04pm

107 Views

Post# 30100146

RE:RE:RE:nice to see ...

I think we need a couple days to confirm. I was hearing from other people that if it was an insider they dont think he has more than 8M which would mean they are close to done as they have done 3.2M in last 30 days and 7M ish since March.

That humanitarian device exemption is also a bonus!

Bullboard Posts

Cybin launches new program phase to treat Major Depressive Disorder